Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration
Open Access
- 27 February 2021
- journal article
- protocol
- Published by MDPI AG in Methods and Protocols
- Vol. 4 (1), 18
- https://doi.org/10.3390/mps4010018
Abstract
The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) causes Coronavirus disease-2019 (COVID-19), which is an ongoing pandemic that has significantly affected the health, economy, and socio-economic status of individuals worldwide. Laboratory research using in vitro, ex vivo and in vivo models has been accelerated to understand the pathogenesis of SARS-CoV-2 infection. However, such experimental research involving SARS-CoV-2 is restricted to biocontainment/safety level-3 (BSL-3) settings, due to the high pathogenicity of this virus. Since many of the downstream analyses of SARS-CoV-2-infected biological samples need to be conducted in a non-BSL3 setting, it is important to ensure that the samples are fully decontaminated and safe for subsequent analysis. Here, we report the effectiveness of standard procedures used to fix cells and tissues for pathological analysis, including 2% or 4% paraformaldehyde, 50%–70% ethanol, 10% neutral buffered formalin and ultrafiltration using membranes with a molecular weight cut-off (MWCO) ranging from 3 to 30 kDa, for inactivating or eliminating SARS-CoV-2. We validated these methods in experimental laboratory samples, such as viral inoculum in cell culture media, SARS-CoV-2 infected host cells and animal tissue lysates. We found that 15 minutes’ treatment of viral inoculum (105 plaque-forming units; PFU) or SARS-CoV-2 infected cells with paraformaldehyde or 70% ethanol resulted in complete inactivation of the virus. The treatment of infected hamster lung tissues with 10% neutral buffered formalin also fully inactivated the virus. However, only 3 kDa ultracentrifuge filter was effective in eliminating the virus to an undetectable limit in the filtrate. Our validated methods are useful for decontaminating biological samples to reduce infection risk and safe handling in BSL2 facilities.Funding Information
- Center for Covid Research and Pandemic Preparedness of Rutgers University (302211)
This publication has 18 references indexed in Scilit:
- Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNAJournal of Clinical Microbiology, 2020
- Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious SamplesViruses, 2020
- Propagation, Inactivation, and Safety Testing of SARS-CoV-2Viruses, 2020
- Airborne transmission of SARS-CoV-2: The world should face the realityEnvironment International, 2020
- A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation PeriodThe Journal of Infectious Diseases, 2020
- Origin and evolution of pathogenic coronavirusesNature Reviews Microbiology, 2018
- New Method Using a Positively Charged Microporous Filter and Ultrafiltration for Concentration of Viruses from Tap WaterApplied and Environmental Microbiology, 2011
- Eukaryotic Viruses in Wastewater Samples from the United StatesApplied and Environmental Microbiology, 2009
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003